Viewing data from:

RABEPRAZOLE SODIUM

ANDA

RABEPRAZOLE SODIUM | A202376 | TORRENT PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: ACIPHEX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.2174

per ea

Lowest NADAC/Unit

$0.2174

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
13668010730RABEPRAZOLE SOD DR 20 MG TAB	$0.2174	EA	Generic	—	2026-06-17
13668010790RABEPRAZOLE SOD DR 20 MG TAB	$0.2174	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain15 active DMFs16 inactive

13 active API suppliers hold Drug Master Files for this ingredient.

DR REDDYS LABORATORIES LTDRABEPRAZOLE SODIUM HYDRATE (FORM Y) USP

DMF 167472003

APITORIA PHARMA PRIVATE LTDRABEPRAZOLE SODIUM

DMF 191862006

TORRENT PHARMACEUTICALS LTDRABEPRAZOLE SODIUM USP

DMF 217362008

DR REDDYS LABORATORIES LTDRABEPRAZOLE SODIUM HYDRATE (FORM-Y), USP

DMF 220312008

SYN-TECH CHEM AND PHARM CO LTDRABEPRAZOLE SODIUM

DMF 234002009

MOEHS IBERICA SLRABEPRAZOLE SODIUM

DMF 249242011

ORCHID PHARMA LTDRABEPRAZOLE SODIUM

DMF 250322011

QUIMICA SINTETICA SARABEPRAZOLE SODIUM (PROCESS II)

DMF 253092011

RAKS PHARMA PVT LTDRABEPRAZOLE SODIUM USP

DMF 256482011

MACLEODS PHARMACEUTICALS LTDRABEPRAZOLE SODIUM

DMF 257112012

ALKEM LABORATORIES LTDRABEPRAZOLE SODIUM USP

DMF 274032013

STERILE INDIA PVT LTDRABEPRAZOLE SODIUM (STERILE)

DMF 299802016

METROCHEM API PRIVATE LTDRABEPRAZOLE SODIUM

DMF 353442020

METROCHEM API PRIVATE LTDRABEPRAZOLE SODIUM (Y-FORM)

DMF 376302022

MAITHRI LABORATORIES PRIVATE LTDRABEPRAZOLE SODIUM USP

DMF 438672026

CIPLA LTDInactiveRABEPRAZOLE SODIUM

DMF 167642003

CADILA HEALTHCARE LTDInactiveRABEPRAZOLE SODIUM

DMF 182262005

LUPIN LTDInactiveRABEPRAZOLE SODIUM USP

DMF 199032006

AMINO CHEMICALS LTDInactiveRABEPRAZOLE SODIUM MONOHYDRATE

DMF 208182007

CADILA PHARMACEUTICALS LTDInactiveRABEPRAZOLE SODIUM

DMF 210342007

CADILA HEALTHCARE LTDInactiveRabeprazole Sodium (Amorphous)

DMF 211922007

MYLAN LABORATORIES LTDInactiveRABEPRAZOLE SODIUM

DMF 212032007

RANBAXY LABORATORIES LTDInactiveRabeprazole Sodium (Non-Sterile Bulk Drug Substance)

DMF 212052007

UQUIFA MEXICO SA DE CVInactiveRABEPRAZOLE SODIUM

DMF 214952008

CHEMO IBERICA SA MADRIDInactiveRABEPRAZOLE SODIUM (PROCESS I)

DMF 215852008

SINTENOVO SA DE CVInactiveRABEPRAZOLE SODIUM

DMF 239072010

ALEMBIC PHARMACEUTICALS LTDInactiveRABEPRAZOLE SODIUM

DMF 248302011

HETERO DRUGS LTDInactiveRABEPRAZOLE SODIUM

DMF 249732011

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveRABEPRAZOLE SODIUM

DMF 253202011

NOSCH LABS PRIVATE LTDInactiveRABEPRAZOLE SODIUM

DMF 269132013

SHANGHAI SINE PHARMACEUTICAL LABORATORIES CO LTDInactiveRABEPRAZOLE SODIUM

DMF 272252013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 20MG

0 patents0 exclusivities▴

TABLET, DELAYED RELEASE;ORAL | Approved: Nov 8, 2013

No patent or exclusivity listings for this strength.